Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MORE-T: High Dose Tamoxifen in Premenopausal Breast Cancer
NCT04997941Phase 2Active, not recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Oct 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tamoxifen in breast cancer, sponsored by Seoul National University Hospital. Started Oct 2021; status: active, not recruiting.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04997941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04997941.